Drug Trial Radar · NCT05030584
A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 52 Weeks in Women Who Have Been Through the Menopause
Last checked: Nov 19, 2026Latest source record: Dec 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
628
Actual
Start
Aug 27, 2021
Primary completion
Mar 29, 2023
Study completion Feb 12, 2024
Sponsor
- Lead sponsor
- BayerBayer (BAYRY)
- Sponsor type
- Industry
- First posted
- Sep 1, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 40 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Researchers are looking for a better way to treat women who have hot flashes after they have been through the menopause. Hot flashes are caused by the hormonal changes that happen when a woman's body has been through the menopause. Menopause is when women stop having a menstrual cycle, also called a period. During the menopause, the ovaries increasingly produce less sex hormones as a result of the natural ageing process and related hormonal adjustments. The decline in hormone production can lead to various symptoms which, in some cases, can have a very adverse effect on a menopausal woman's quality of life. The study treatment, elinzanetant, was developed to treat symptoms caused by hormonal changes. It works by blocking a protein called neurokinin from sending signals to other parts of the body, which is thought to play a role in starting hot flashes. There are treatments for hot flashes in women who have been through the menopause, but may cause medical problems for some people. In this study, the researchers will learn how well elinzanetant works compared to a placebo in women who have been through the menopause and have hot flashes. A placebo is a treatment that looks like a medicine but does not have any medicine in it. To compare these study treatments, the participants will record information about their hot flashes in an electronic diary. The researchers will study the number of hot flashes the participants have and how severe they are. They will study the results from before treatment and after 12 weeks of treatment. The participants in this study will take two capsules of either elinzanetant or the placebo once a day. The participants will take the study treatments for 52 weeks. During the study, the participants will visit their study site approximately 11 times and perform 2 visits by phone. Each participant will be in the study for approximately 62 weeks. During the study, the participants will: * record information about their hot flashes in an electronic diary * answer questions about their symptoms The doctors will: * check the participants' health * take blood samples * ask the participants questions about what medicines they are taking and if they are having adverse events An adverse event is any medical problem that a participant has during a study. Doctors keep track of all adverse events that happen in studies, even if they do not think the adverse events might be related to the study treatments.
Conditions
- Vasomotor Symptoms Associated With Menopause
- Hot Flashes
Interventions
Elinzanetant (BAY3427080)Drug
120 mg elinzanetant orally once daily
PlaceboDrug
Matching placebo orally once daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change in Frequency of Moderate to Severe Hot Flashes (HFs) From Baseline to Week 12 (Assessed by Hot Flash Daily Diary [HFDD])Time frame: Baseline to Week 12
Locations
86 sites in 9 countries. Site status is shown where the registry gives one.
Mobile ObGyn, P.C. | Mobile, AL
Mobile, Alabama
Mesa Obstetricians and Gynecologists | Research Department
Mesa, Arizona
National Institute of Clinical Research - Garden Grove
Garden Grove, California
Marvel Clinical Research | Huntington Beach, CA
Huntington Beach, California
Empire Clinical Research | Pomona, CA
Pomona, California
Coastal Connecticut Research | New London, CT
New London, Connecticut
IntimMedicine | Washington, DC
Washington D.C., District of Columbia
Boca Midwifery
Boca Raton, Florida
Helix Biomedics LLC | Boynton Beach, FL
Boynton Beach, Florida
UF Health Women's Specialists - Emerson
Jacksonville, Florida
Suncoast Clinical Research - Palm Harbor
Palm Harbor, Florida
Physician Care Clinical Research LLC | Sarasota, FL
Sarasota, Florida
Suncoast Clinical Research - New Port Richey
Trinity, Florida
Paramount Research Solutions | College Park Location
College Park, Georgia
Investigators Research Group, LLC
Brownsburg, Indiana
Southern Clinical Research Associates
Metairie, Louisiana
Southern Clinical Research, LLC
Zachary, Louisiana
Johns Hopkins Hospital - Gynecology and Obstetrics
Baltimore, Maryland
Boeson Research | Great Falls, MT
Great Falls, Montana
Boeson Research | Missoula, MT
Missoula, Montana
Affiliated Clinical Research, Inc. | Las Vegas, NV
Las Vegas, Nevada
AMR - Las Vegas
Las Vegas, Nevada
Elite Clinical Network (ECN) | Las Vegas Clinical Trials, LLC
North Las Vegas, Nevada
M3 Wake Research | Raleigh, NC
Raleigh, North Carolina
ClinOhio Research Services, LLC. | Columbus, OH
Columbus, Ohio
HWC Women's Research Center | Englewood, OH
Englewood, Ohio
Clinical Research Philadelphia | Philadelphia, PA
Philadelphia, Pennsylvania
Venus Gynecology, LLC | Myrtle Beach, SC
Myrtle Beach, South Carolina
Advances in Health, INC. | Houston, TX
Houston, Texas
UTHealth Womens Research Program | Memorial City
Houston, Texas
Elligo Health Research | Medical Colleagues of Texas
Hurst, Texas
Elligo Health Research | Protenium Clinical Research
Katy, Texas
Maximos Ob/Gyn
League City, Texas
Tidewater Clinical Research - Norfolk
Norfolk, Virginia
Eastern Virginia Medical School | OB/GYN Clinical Research Center
Norfolk, Virginia
Seattle Clinical Research Center
Seattle, Washington
CHU Saint-Pierre/UMC Sint-Pieter
Bruxelles - Brussel, Belgium
UZ Gent
Ghent, Belgium
UZ Leuven Gasthuisberg
Leuven, Belgium
CHU de Liege | CHR Citadel - Department of Gyneacology and Obstetrics
Liège, Belgium
Showing 40 of 86 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.